• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脱氧腺苷加脱氧助间型霉素对人淋巴母细胞及分离细胞核中DNA复制和修复合成的影响。

The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.

作者信息

Matsumoto S S, Yu J, Yu A L

机构信息

Department of Pediatrics, University of California, San Diego, La Jolla 92093.

出版信息

J Biol Chem. 1988 May 25;263(15):7153-8.

PMID:3259231
Abstract

Deoxyadenosine plus deoxycoformycin (dCf) causes increased DNA breaks in lymphoid cells. This study explored the possible inhibition of repair synthesis of DNA by dAdo plus dCf as a cause of DNA breakage. It was shown that DNA breaks accumulated in a human T-lymphoblast cell line, CCRF-CEM, following incubation with dAdo plus dCf and were not fully repaired 20 h after their removal. Analysis of the density distribution of radiolabeled DNA on alkaline CsCl gradient showed that incubation of CCRF-CEM cells with dAdo plus dCf caused inhibition of semiconservative, but not repair synthesis of DNA. Semiconservative synthesis of DNA was also inhibited in CCRF-CEM nuclei isolated from cells pretreated with dAdo and dCf, suggesting damage to DNA replicative machinery. However, no such inhibition was observed in the nuclei of a similarly treated CCRF-CEM mutant that was deficient in adenosine kinase and deoxycytidine kinase. This suggests that dAdo must be phosphorylated in intact cells to exert its effect. Using [3H]dTTP incorporation in isolated CCRF-CEM nuclei to measure DNA synthesis, it was found that a high concentration (greater than 100 microM) of dATP inhibits semiconservative but not repair synthesis of DNA. The present studies thus indicate that accumulation of DNA strand breaks induced by dAdo plus dCf is not the consequence of inhibition of repair DNA synthesis. This implies the mechanism may involve perturbation of DNA ligation or activation of a certain process which causes DNA strand breaks. In addition, dATP may interfere with some steps of semiconservative DNA synthesis, but not the repair synthesis of DNA.

摘要

脱氧腺苷加脱氧助间型霉素(dCf)会导致淋巴细胞中的DNA断裂增加。本研究探讨了脱氧腺苷加脱氧助间型霉素对DNA修复合成的可能抑制作用,以此作为DNA断裂的一个原因。结果显示,在人T淋巴母细胞系CCRF - CEM中,用脱氧腺苷加脱氧助间型霉素孵育后,DNA断裂会累积,且在去除药物后20小时仍未完全修复。对放射性标记的DNA在碱性CsCl梯度上的密度分布分析表明,用脱氧腺苷加脱氧助间型霉素孵育CCRF - CEM细胞会抑制DNA的半保留合成,但不抑制DNA的修复合成。从用脱氧腺苷和脱氧助间型霉素预处理过的细胞中分离出的CCRF - CEM细胞核内,DNA的半保留合成也受到抑制,这表明DNA复制机制受到了损害。然而,在腺苷激酶和脱氧胞苷激酶缺陷的类似处理的CCRF - CEM突变体的细胞核中未观察到这种抑制作用。这表明脱氧腺苷必须在完整细胞中磷酸化才能发挥其作用。利用[3H]胸苷三磷酸掺入分离出的CCRF - CEM细胞核中来测量DNA合成,发现高浓度(大于100 microM)的脱氧三磷酸腺苷抑制DNA的半保留合成,但不抑制DNA的修复合成。因此,目前的研究表明,脱氧腺苷加脱氧助间型霉素诱导的DNA链断裂的积累不是抑制修复性DNA合成的结果。这意味着其机制可能涉及DNA连接的扰动或导致DNA链断裂的某个过程的激活。此外,脱氧三磷酸腺苷可能会干扰DNA半保留合成的某些步骤,但不会干扰DNA的修复合成。

相似文献

1
The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.脱氧腺苷加脱氧助间型霉素对人淋巴母细胞及分离细胞核中DNA复制和修复合成的影响。
J Biol Chem. 1988 May 25;263(15):7153-8.
2
Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.在体外,用2'-脱氧助间型霉素和脱氧腺苷处理的受辐照小鼠L5178Y淋巴母细胞和人慢性淋巴细胞白血病细胞中,细胞毒性增强且DNA损伤修复受到抑制。
Cancer Res. 1988 Jul 15;48(14):3981-6.
3
Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes.脱氧腺苷加脱氧助间型霉素对静止淋巴细胞RNA合成的抑制作用。
J Immunol. 1983 Dec;131(6):2762-6.
4
Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.脱氧腺苷对静息人淋巴细胞DNA修复的抑制作用。
J Immunol. 1986 Apr 15;136(8):2839-43.
5
Differential sensitivity of leukemic cells to growth inhibition by deoxyadenosine and deoxycoformycin.
Tohoku J Exp Med. 1985 Dec;147(4):331-41. doi: 10.1620/tjem.147.331.
6
Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.在经脱氧腺苷、脱氧助间型霉素和干扰素处理的人T淋巴母细胞系中诱导产生的2',5'-寡腺苷酸合成酶抑制剂
Biochem Biophys Res Commun. 1985 Mar 29;127(3):1019-25. doi: 10.1016/s0006-291x(85)80046-2.
7
Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.人T淋巴细胞和B淋巴细胞杂交细胞中脱氧腺苷毒性的决定因素,作为T细胞急性淋巴细胞白血病耐药性发展的模型
Cancer Res. 1985 Apr;45(4):1579-86.
8
The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells.脱氧助间型霉素和脱氧腺苷对白血病细胞中脱氧核糖核苷酸浓度的影响。
Br J Haematol. 1982 Aug;51(4):623-30. doi: 10.1111/j.1365-2141.1982.tb02826.x.
9
DNA repair in nondividing human lymphocytes: inhibition by deoxyadenosine.非分裂期人淋巴细胞中的DNA修复:脱氧腺苷的抑制作用
Cancer Res. 1986 Apr;46(4 Pt 1):1585-8.
10
Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin.使用单克隆抗体联合2'-脱氧助间型霉素清除克隆形成性恶性人T细胞
J Clin Oncol. 1987 Dec;5(12):1900-11. doi: 10.1200/JCO.1987.5.12.1900.

引用本文的文献

1
Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.喷司他丁。对其药效学和药代动力学特性以及在淋巴增殖性疾病中的治疗潜力的综述。
Drugs. 1993 Oct;46(4):652-77. doi: 10.2165/00003495-199346040-00006.
2
DNA fragmentation in permeabilized cells and nuclei. The role of (Ca2+ + Mg2+)-dependent endodeoxyribonuclease.通透细胞和细胞核中的DNA片段化。(Ca2+ + Mg2+)依赖性内切脱氧核糖核酸酶的作用。
Biochem J. 1989 Jul 1;261(1):17-21. doi: 10.1042/bj2610017.
3
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
2-氯脱氧腺苷在体外和体内对人单核细胞具有强大毒性。一种免疫抑制治疗的新方法。
J Clin Invest. 1990 Nov;86(5):1480-8. doi: 10.1172/JCI114865.
4
Factors influencing the inhibition of repair of irradiation-induced DNA damage by 2'-deoxycoformycin and deoxyadenosine.影响2'-脱氧助间型霉素和脱氧腺苷对辐射诱导的DNA损伤修复抑制作用的因素。
Cancer Chemother Pharmacol. 1992;30(1):65-9. doi: 10.1007/BF00686487.